I wonder what would be fair multiple to price OPT providing that...

I wonder what would be fair multiple to price OPT providing that both trials are successful.
Let say marketing approval will not come before end of CY26 - CY27 sales might be a few hundred million then CY28 might be around $700-800M followed by $1B plus in CY29.

So maybe we need to consider next 5 years of earnings to factor SP.

Based on my rough conservative assumptions - OPT will make possibly $3B in revenue from 2025-2030.. which may result in earnings of $2B (assuming 30% margin)

$2B / 5 equals avg of 400M per year. Apply that with a PE of 10 gives a market cap 4B.


The divide 4B by the number of shares gives 4B / 1.3B = $3 SP

Interested to hear everyone’s thoughts on this.